12月18日，保龄宝盘中上涨2.01%，截至13:27，报9.15元/股，成交5651.47万元，换手率1.69%，总市值 34.82亿元。 资金流向方面，主力资金净流入348.18万元，特大单买入145.56万元，占比2.58%，卖出0.00元，占比 0.00%；大单买入966.92万元，占比17.11%，卖出764.30万元，占比13.52%。 保龄宝今年以来股价涨25.00%，近5个交易日涨4.69%，近20日跌3.68%，近60日跌10.99%。 保龄宝所属申万行业为：农林牧渔-农产品加工-其他农产品加工。所属概念板块包括：代糖概念、合成 生物、生物医药、小盘、增持回购等。 截至12月10日，保龄宝股东户数3.43万，较上期减少0.37%；人均流通股10773股，较上期增加0.38%。 2025年1月-9月，保龄宝实现营业收入21.26亿元，同比增长15.98%；归母净利润1.34亿元，同比增长 32.58%。 分红方面，保龄宝A股上市后累计派现3.09亿元。近三年，累计派现9507.22万元。 责任编辑：小浪快报 今年以来保龄宝已经5次登上龙虎榜，最近一次登上龙虎榜为5月22日，当日龙虎榜净买入-5 ...

Core Viewpoint - The stock of Haoyuan Pharmaceutical has experienced a decline of 2.05% on December 18, 2023, despite a year-to-date increase of 100.54% [1] Group 1: Company Overview - Haoyuan Pharmaceutical, established on September 30, 2006, and listed on June 8, 2021, is located in Shanghai and specializes in the research and development of small molecule drug discovery, including molecular building blocks and tool compounds [2] - The company's main business revenue composition includes molecular building blocks and tool compounds (68.97%), with product sales contributing 63.42%, raw materials and intermediates 30.46%, and technical services 5.55% [2] - As of September 30, 2023, the number of shareholders is 12,000, a decrease of 6.34% from the previous period, with an average of 17,647 circulating shares per person, an increase of 6.77% [2] Group 2: Financial Performance - For the period from January to September 2023, Haoyuan Pharmaceutical achieved a revenue of 2.059 billion yuan, representing a year-on-year growth of 27.18%, and a net profit attributable to shareholders of 237 million yuan, up 65.09% year-on-year [2] - The company has distributed a total of 160 million yuan in dividends since its A-share listing, with 120 million yuan distributed over the past three years [3] Group 3: Stock Market Activity - On December 18, 2023, Haoyuan Pharmaceutical's stock price was reported at 71.13 yuan per share, with a trading volume of 111 million yuan and a turnover rate of 0.73%, resulting in a total market capitalization of 15.087 billion yuan [1] - The stock has seen a net outflow of 2.4429 million yuan from major funds, with significant buying and selling activities recorded [1] - The stock has appeared on the "Dragon and Tiger List" once this year, with the last occurrence on May 30, 2023, where it recorded a net purchase of 10.336 million yuan [1]

今年以来，AI、生物医药均是港股市场爆火的板块，阿里巴巴（09988.HK）、百济神州（06160.HK）、信达生物（01801.HK）等概念股实现大涨。 公告披露，英矽智能拟将募资净额投往这些方向：约48.0%用于为关键临床阶段管线候选药物的进一步临床研发提供资金；约15.0%用于开发新的生成式AI 模型及相关验证研究工作；约12.0%用于进一步开发及扩展自动化实验室；约20.0%用于早期药物发现及开发（包括其他管线候选药物的临床前及临床阶 段）的研发资金；约5.0%用于营运资金及一般公司用途。 值得一提的是，英矽智能此次发行获得了众多知名基石投资者的支持，包括腾讯（00700.HK）、Oaktree、Schroders、淡马锡、瑞银、华夏基金、中国太 保、易方达基金管理等。在满足相关条件后，基石投资者或其指定实体认购总金额为1.15亿美元的首次公开募股。 而在12月18日，有一只叠加了AI、生物医药双重概念的企业——英矽智能（03696.HK）在港股市场开启了招股。 根据全球发售资料，英矽智能招股时间为18日至23日，预期将于12月30日上市。 英矽智能此次全球发售约9469.05万股股份（视乎超额配股权 ...

Group 1 - The core viewpoint of the articles indicates that Xintiandi's stock has shown fluctuations, with a current price of 11.94 CNY per share and a market capitalization of 4.681 billion CNY, reflecting a year-to-date increase of 24.47% [1] - The company has experienced a net inflow of main funds amounting to 21.93 thousand CNY, with significant buying and selling activities recorded [1] - Xintiandi has appeared on the trading leaderboard 14 times this year, with the most recent occurrence on June 9, where it recorded a net buy of -20.0864 million CNY [1] Group 2 - As of December 10, the number of Xintiandi shareholders decreased to 18,300, while the average circulating shares per person increased by 1.85% to 21,414 shares [2] - For the period from January to September 2025, Xintiandi reported a revenue of 481 million CNY, representing a year-on-year decrease of 10.42%, and a net profit attributable to shareholders of 91.907 million CNY, down 35.19% year-on-year [2] - Since its A-share listing, Xintiandi has distributed a total of 259 million CNY in dividends [3]

本报北京12月17日电 （记者吴丹）记者从教育部获悉：12月15日至17日，2025高校科技成果交易会在 广东省广州市举行，吸引全国600余所高校参展，集中展示新一代信息技术、新能源、生物医药、低空 经济等战略性新兴产业领域的前沿科技成果。 (责编：胡永秋、杨光宇) 活动现场，"高校成果超市区"集中推介高价值成果和专利，"港澳高校成果推介区"深化粤港澳大湾区资 源互通，"大学生创业示范区"挖掘新生代科创潜力。同时，创新设立多元化特色板块与交易机制，设 立"一站式"服务区提供全流程支持。 《 人民日报 》（ 2025年12月18日 06 版） ...

12月16日，在2025上证多层次资本市场高质量发展大会暨上证鹰·金融资、金阳光、诚信托颁奖仪式上，国寿股权投资有限公司董事总经理姜黎表示，未来 的投资方向，公司除了坚持此前布局的生物医药、医疗器械以及半导体产业，还会重点布局AI（人工智能）、AI+、具身智能机器人等领域。 上证报中国证券网讯（记者 王墨璞嘉）12月16日，在2025上证多层次资本市场高质量发展大会暨上证鹰·金融资、金阳光、诚信托颁奖仪式上，国寿股权投 资有限公司董事总经理姜黎表示，未来的投资方向，公司除了坚持此前布局的生物医药、医疗器械以及半导体产业，还会重点布局AI（人工智能）、AI+、 具身智能机器人等领域。 作为国央企的金融企业，国寿股权投资有限公司对于风险的敏感度较高。姜黎表示，对于行业发展尚处于早期的新兴领域，公司也会积极探索投资方式。虽 有一定的挑战，但正在摸索之中。 官网显示，国寿股权投资有限公司于2016年6月在中国（上海）自由贸易试验区正式成立，是中国人寿旗下专业化私募股权投资平台，致力于发挥中国人寿 的资源优势，做长期的价值投资者和共享共赢的合作伙伴。 姜黎介绍称，国寿股权投资有限公司当前搭建了四期基金，合计规模达320 ...

Core Viewpoint - The Central Financial Office projects that China's economy is expected to grow by around 5% in 2025, reaching a total economic volume of approximately 140 trillion yuan [1][2]. Group 1: Economic Performance - The overall economic operation is stable, with major economic indicators meeting expectations, and a projected annual growth rate of around 5%, keeping China among the leading major economies globally [1]. - Employment remains generally stable, with rapid growth in foreign trade and significant diversification in exports [1]. Group 2: Industrial Development - The construction of a modern industrial system is continuously advancing, with steady development of new productive forces and abundant technological innovation achievements [1]. - Research and application in artificial intelligence, biomedicine, and robotics are leading globally [1]. Group 3: Reform and Opening Up - New steps have been taken in reform and opening up, with the construction of a unified national market progressing deeply [1]. - Comprehensive rectification of "involution" competition has shown positive results, and the capital market remains active with orderly self-opening [1]. Group 4: Risk Management - Positive progress has been made in resolving key area risks, including orderly replacement of local government hidden debts and the completion of "guaranteeing housing delivery" tasks [1]. - Significant results have been achieved in the reform of small and medium financial institutions, maintaining a baseline to prevent systemic risks [1]. Group 5: Social Welfare - Strengthened social welfare measures include the implementation of childcare subsidies and one year of free preschool education, contributing to the continuous improvement of social security levels [2]. - The overall social situation remains stable, with economic and social development goals expected to be successfully achieved, aiding in the completion of the "14th Five-Year Plan" [2]. Group 6: Future Outlook - The active flow of factors and innovation is expected to continuously inject new momentum into development, with rapid growth in the flow of people, logistics, information, and capital [2]. - Investment and consumption growth rates are anticipated to recover next year, accelerating industrial transformation and upgrading, with a concentrated outbreak of technological and industrial innovation achievements [2].

Core Viewpoint - The article discusses the outcomes and expectations of China's economic performance as it approaches the end of the 14th Five-Year Plan and the beginning of the 15th, highlighting the resilience and vitality of the economy despite challenges [1][2]. Economic Performance and Outlook - The overall economic operation is stable, with a projected growth rate of around 5% for the year, leading to an economic total of approximately 140 trillion yuan [1]. - The construction of a modern industrial system is progressing, with advancements in technology and innovation, particularly in artificial intelligence, biomedicine, and robotics [1]. - Reforms and opening-up measures are advancing, with a focus on building a unified national market and addressing "involution" competition [2]. - There are positive developments in risk mitigation in key areas, including the orderly replacement of local government hidden debts and the completion of housing delivery tasks [2]. Challenges and Policy Directions - The article identifies ongoing challenges such as external environmental changes, weak domestic demand, and risks in key sectors [2]. - The economic foundation remains strong, with long-term supportive conditions for growth, including the advantages of the socialist system and a large market [3]. - The government plans to implement more proactive macroeconomic policies, maintaining necessary fiscal deficits and debt levels while enhancing the precision and effectiveness of fiscal spending [3][4]. Domestic Demand and Investment - Expanding domestic demand is a top priority, with domestic demand contributing 71% to economic growth in the first three quarters [5]. - The government aims to stimulate consumption by addressing structural changes and enhancing the supply of quality goods and services [5][6]. - Investment is expected to stabilize, with a focus on infrastructure and social welfare projects, while also encouraging private investment in high-tech and service sectors [6]. Technological Innovation and Market Development - The construction of international technology innovation centers in Beijing, Shanghai, and the Guangdong-Hong Kong-Macau Greater Bay Area is emphasized as a strategic move to enhance global competitiveness [7][8]. - The article discusses the need for a unified national market to improve resource allocation and market efficiency, addressing barriers to competition and market entry [9][10]. Trade and Foreign Investment - The government plans to expand high-level opening-up measures, including increasing service sector access and signing more trade agreements [11][12][13]. - Efforts will be made to optimize the business environment for foreign investment, including easing market access and enhancing support for foreign enterprises [13]. Regional Development and Coordination - The article outlines strategies for promoting regional coordinated development, focusing on the collaborative growth of different regions and supporting major economic provinces [14][15][16]. - Emphasis is placed on urban-rural integration and the development of new productive forces tailored to local conditions [15]. Green Transition and Employment - The government is committed to a green transition, with plans to achieve carbon peak and neutrality goals while enhancing the resilience of the energy system [16][17][18]. - Employment policies will focus on stabilizing job growth, particularly for key groups such as graduates and migrant workers, while promoting flexible employment and skills training [19][20]. Real Estate Market Stability - The article discusses the need for a stable real estate market, highlighting the potential for high-quality development despite current challenges [21][22]. - Measures will be taken to support the transformation of real estate companies and to encourage a new development model in the sector [22][23].

来源：新华社 在"十四五"即将收官、"十五五"新程待启的关键时点，2025年12月10日至11日召开的中央 经济工作会议备受瞩目。 当前经济形势怎么看？"十五五"新开局重点任务如何推进？聚焦舆论关注的热点问题，中央 财办有关负责同志会后第一时间接受中央主要媒体采访，深入解读中央经济工作会议精神。 问：2025年我国交出怎样的经济"成绩单"？明年经济形势如何? 答： 中央经济工作会议对今年经济工作进行全面总结，指出2025年是很不平凡的一年，我国 经济顶压前行、向新向优发展，展现强大韧性和活力。 一是运行总体平稳、稳中有进。 主要经济指标符合预期，预计全年经济增长5%左右、继续位 居世界主要经济体前列，经济总量有望达到140万亿元左右。就业总体稳定，外贸较快增长、 出口多元化成效明显。 二是现代化产业体系建设持续推进。 新质生产力稳步发展，科技创新成果丰硕，人工智能、 生物医药、机器人等研发应用走在全球前列。 三是改革开放迈出新步伐。 全国统一大市场建设向纵深推进，综合整治"内卷式"竞争成效显 现，资本市场较为活跃，自主开放有序推进。 四是重点领域风险化解取得积极进展。 地方政府隐性债务有序置换，"保交房"任务 ...

北京市发展和改革委员会党组书记、主任杨秀玲接受专访时强调，北京要加快围绕现代化产业体系，强 化中试等产业平台建设，推动人工智能、生物医药、机器人等优势领域做大做强，加速布局6G、量 子、生物制造、脑机接口等新赛道，大力发展现代服务业，扎实推动高质量发展。（中新网） ...